Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0229 | 0.7487 | 0.7487 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.1803 | 0.1803 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0245 | 0.8197 | 0.8197 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0286 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0113 | 0.246 | 0.246 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0229 | 0.7487 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0171 | 0.4963 | 0.4963 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.684 | 0.684 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0266 | 0.0266 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0083 | 0.117 | 0.117 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0098 | 0.1803 | 0.1803 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0228 | 0.7477 | 0.7477 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.4316 | 0.4316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0228 | 0.7477 | 0.7477 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.684 | 0.684 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0286 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0063 | 0.0266 | 0.0266 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.4316 | 0.4316 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.008 | 0.1009 | 0.1009 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0092 | 0.1542 | 0.1542 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0113 | 0.246 | 0.246 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0228 | 0.7477 | 0.7477 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0079 | 0.0976 | 0.0976 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0098 | 0.1803 | 0.1803 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0121 | 0.279 | 0.279 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0098 | 0.1803 | 0.1803 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0113 | 0.246 | 0.246 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0113 | 0.246 | 0.246 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.4327 | 0.4327 |
Giardia lamblia | GTOR | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.4327 | 0.4327 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0286 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0098 | 0.1803 | 0.1803 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.006 | 0.0167 | 0.0167 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0098 | 0.1803 | 0.1803 |
Entamoeba histolytica | hypothetical protein | 0.0094 | 0.1618 | 0.1618 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0098 | 0.1803 | 0.1803 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0229 | 0.7487 | 0.7487 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.4327 | 0.4327 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.1803 | 0.1803 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0113 | 0.246 | 0.246 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0286 | 1 | 1 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.008 | 0.1009 | 0.1009 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.684 | 0.684 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0172 | 0.5037 | 0.5037 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0083 | 0.117 | 0.117 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0137 | 0.35 | 0.35 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0177 | 0.5246 | 0.5246 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.4327 | 0.4327 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0083 | 0.1173 | 0.1173 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0196 | 0.6087 | 0.6087 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0286 | 1 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0063 | 0.0266 | 0.039 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0098 | 0.1803 | 0.1803 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0094 | 0.1618 | 0.1618 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0172 | 0.5037 | 0.5037 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0228 | 0.7477 | 0.7477 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0214 | 0.684 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.4316 | 0.4316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.684 | 0.684 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0196 | 0.6087 | 0.6087 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0286 | 1 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0286 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.684 | 0.684 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0196 | 0.6087 | 0.6087 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1009 | 0.1009 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0098 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0171 | 0.4963 | 0.4963 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0228 | 0.7477 | 0.7477 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.684 | 0.684 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.008 | 0.1009 | 0.1009 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0059 | 0.0059 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.684 | 0.684 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0187 | 0.5673 | 0.5673 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0113 | 0.246 | 0.246 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0286 | 1 | 1 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0286 | 1 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0098 | 0.1803 | 0.1803 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0098 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0193 | 0.594 | 0.594 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0113 | 0.246 | 0.246 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0172 | 0.5037 | 0.5037 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.